Log In
Print
BCIQ
Print
Print this Print this
 

DP-VPA

Also known as: SPD 421

  Manage Alerts
Collapse Summary General Information
Company D-Pharm Ltd.
DescriptionPhospholipid derivative of valproic acid formulated with D-Pharm's Regulated Activation of Prodrugs (RAP) technology
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today